Stephen Kaar

9PUBLICATIONS
25CO-AUTHORS
Counselling, wellbeing and community servicesClinical pharmacology and therapeuticsMedical infection agents (incl. prions)Health psychologyCircuits and systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 11, 2026
From healthcare encounters to policy: Patient and stakeholder perspectives on how stigma undermines care for people with substance use disorders and multiple disadvantages.

|Feb 24, 2026
Evidence-based consensus guidelines for the pharmacological management of substance dependence: Recommendations from the British Association for Psychopharmacology.

Julia Ma Sinclair, Nicola J Kalk, Stephen J Kaar

|Sep 05, 2025
The role of low subcortical iron, white matter myelin, and oligodendrocytes in schizophrenia: a quantitative susceptibility mapping and diffusion tensor imaging study.

Luke J Vano, Robert A McCutcheon, Jan Sedlacik

|May 05, 2025
Treatment Engagement and Healthcare Utilization Outcomes from a Mixed Methods Study of the Implementation of Alcohol Assertive Outreach in the North West of England.

Nikolaos Mylonas, Laura Helen Scoles, Aansha Priyam

|Jan 02, 2023
Gamma Oscillations and Potassium Channel Modulation in Schizophrenia: Targeting GABAergic Dysfunction.

Stephen J Kaar, Judith F Nottage, Ilinca Angelescu

|Sep 27, 2022
The effect of AUT00206, a Kv3 potassium channel modulator, on dopamine synthesis capacity and the reliability of [18F]-FDOPA imaging in schizophrenia.

Ilinca Angelescu, Stephen J Kaar, Tiago Reis Marques

Pageof 2

Frequent Collaborators

2 joint publications

Nikolaos Mylonas

1 joint publications

Ilinca Angelescu

1 joint publications

Laura Helen Scoles

1 joint publications

Aansha Priyam